Follow us on :


Vascular Diseases and Therapeutics

Online ISSN: 2399-7400

Wilbert S. Aronow MD (Editor-in-Chief)

Harvard Medical School

Vascular Diseases and Therapeutics (VDT) is a bimonthly, open access, peer-reviewed journal which considers manuscripts on diagnosis and treatment of vascular and related diseases.

Manuscripts may take the form of original empirical research, critical reviews of the literature, brief commentaries, meeting reports, case reports, innovations in clinical practice, letters and drug clinical trial studies.

VDT welcomes direct submissions from authors: Attach your word file with e-mail and send it to: submissions@oatext.com alternatively to: editor.vdt@oatext.com

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by VDT, is properly cited.

Wilbert S. Aronow MD


Wilbert S. Aronow MD is Professor of Medicine at New York Medical College/Westchester Medical Center, Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 14 books and is author or co-author of 1,521 papers, 399 commentaries or Letters to the Editor, and 1,047 abstracts and is presenter or co-presenter of 1,410 talks at meetings. Dr. Aronow is a Fellow of the ACC, the AHA, the ACP, the ACCP, the ASPC, the AGS (Founding Fellow of Western Section), and the GSA. He has been a member of 144 editorial boards of medical journals, editor-in-chief of 2 journals, co-editor of 2 journals, deputy editor of 1 journal, executive editor of 2 journals, associate editor for 9 journals, and guest editor for 7 other medical journals.

He has received each year from 2001-2016 an outstanding teacher and researcher award from the medical residents and from 2001-2016 from the cardiology fellows at Westchester Medical Center/New York Medical College. He has received awards from the Society of Geriatric Cardiology, the Gerontological Society of America, New York Medical College including the 2014 Chancellor’s Research Award, the F1000 Faculty Member of the Year Award for the Faculty of Cardiovascular Disorders in 2011, 2013, 2014, and 2015, the Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in July, 2010, and a Distinguished Fellowship Award from the International Academy of Cardiology in July, 2012.

He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure, co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and is currently a member of the writing group of the 2017ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ ASH/ASPC/NMA/PCNA guidelines for the management of patients with hypertension. He was a coauthor of a 2015 position paper from the International Lipid Expert Forum.

He was a consultant to the ACP Information and Educational Resource (PIER) on the module of aortic stenosis, a member of the Board of Directors of the ASPC, a member of the ACCP Cardiovascular Medicine and Surgery Network Steering Committee, and a member of the Scientific Executive Committee of the International Academy of Cardiology. He was a peer reviewer of the 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA/HFSA Guideline for the Management of Heart Failure.

Associate Editors

Mahboob Alam

Department of Medicine, Section of Cardiology
Baylor College of Medicine
Houston USA

Suresh Krishnamoorthy

Consultant in Cardiology
George Eliot Hospital NHS Trust, Nuneaton
England

Waleed Abdou Ibrahim Hamed

Assistant professor of Cardiology Menoufia University
Egypt


Mark Laftavi

Director, Pancreas Transplant Program
Upstate Hospital University, USA

Khalid Bin Thani

Cardiology Division, Internal Medicine Department
Salmaniya Medical Complex, Ministry of Health
Manama, Bahrain

Nivas Balasubramaniyam

Interventional Cardiology Fellow, Mount Sinai Medical Center
New York, USA


Burton M Altura

Professor
Pharmacology & Medicine
SUNY Downstate Medical Center
USA

Editorial Board

Laurie Renae Armsby

Director of Pediatric Cardiology Fellowship
Oregon Health & Science University
USA

Kanat OZISIK

Professor, Cardiovascular Surgery Specialist
Kafkas University Medical School
Turkey

Hazem Khamis

Associated professor & Head of cardiology Department
October 6th University
Egypt


Mohammad A Amarneh

Pediatric Radiology Fellowship
University of Iowa Hospitals and Clinics
USA

Giuseppe Murdaca

Department of Internal Medicine, University of Genova
Genova
Italy

Khaled N. Leon

The National Heart Institute
Imbaba, Cairo, Egypt


Ankush Sharma

Institute of Clinical Physiology
National Research Council
Siena, Italy

Andrea Ballini

Clinical Investigator Department of Basic Medical Sciences
Neurosciences and Sense Organs
School of Medicine
University of Bari Aldo Moro Italy

Leonardo Roever

Department of Clinical Research
Federal University of Uberlândia
Brazil


Emilka Mikołajewska

Department of Physiotherapy
Ludwik Rydygier Collegium Medicum
Nicolaus Copernicus University, Poland

Guang Hao

Medical College of Georgia
Augusta University, Augusta
USA


In Press

Volume 2, Issue 6


Will be updated soon.

Current Issue

Volume 2, Issue 5


Angio-seal infection: An uncommon but serious and alarming complication of vascular closure devices

Pradeep Kumar Mada Liam Morris Pavan Katikaneni Andrew Stevenson Joel Chandranesan

Case Report-Vascular Diseases and Therapeutics (VDT)

June 26, 2017


Thrombocytopenia in critically ill patients due to vascular microthrombotic disease: pathogenesis based on “two activation theory of the endothelium”

Jae C. Chang

Review Article-Vascular Diseases and Therapeutics (VDT)

June 30, 2017


Warning at emergency room: The role of diagnostic test in acute aortic dissection

Alfonso Lagi

Review Article-Vascular Diseases and Therapeutics (VDT)

July 03, 2017


Effect of UPPP on vascular reactivity of patients with OSAS

Vural Fidan Leman Veziroglu Birdane

Research Article-Vascular Diseases and Therapeutics (VDT)

July 07, 2017


A novel CYP7A1 polymorphism is associated with the low-density lipoprotein cholesterol response to atorvastatin

Zhi-Ke Liu Wotan Zeng Yan Zhang Jia Jia Jian-Ping Li Yong Huo Da-Fang Chen

Research Article-Vascular Diseases and Therapeutics (VDT)

July 10, 2017


Carotid body tumors: A report of three cases and current literature review

Ayhan Muduroglu Ahmet Yuksel

Case Series-Vascular Diseases and Therapeutics (VDT)

August 26, 2017


Archive


Volume 2

Angio-seal infection: An uncommon but serious and alarming complication of vascular closure devices

Pradeep Kumar Mada Liam Morris Pavan Katikaneni Andrew Stevenson Joel Chandranesan

Case Report-Vascular Diseases and Therapeutics (VDT)

June 26, 2017


Thrombocytopenia in critically ill patients due to vascular microthrombotic disease: pathogenesis based on “two activation theory of the endothelium”

Jae C. Chang

Review Article-Vascular Diseases and Therapeutics (VDT)

June 30, 2017


Warning at emergency room: The role of diagnostic test in acute aortic dissection

Alfonso Lagi

Review Article-Vascular Diseases and Therapeutics (VDT)

July 03, 2017


Effect of UPPP on vascular reactivity of patients with OSAS

Vural Fidan Leman Veziroglu Birdane

Research Article-Vascular Diseases and Therapeutics (VDT)

July 07, 2017


A novel CYP7A1 polymorphism is associated with the low-density lipoprotein cholesterol response to atorvastatin

Zhi-Ke Liu Wotan Zeng Yan Zhang Jia Jia Jian-Ping Li Yong Huo Da-Fang Chen

Research Article-Vascular Diseases and Therapeutics (VDT)

July 10, 2017


Carotid body tumors: A report of three cases and current literature review

Ayhan Muduroglu Ahmet Yuksel

Case Series-Vascular Diseases and Therapeutics (VDT)

August 26, 2017


QT prolongation by ranitidine in hypokalemia and arrhythmogen provoked rat heart

Sanmoy Karmakar Md Asif Ali Rammohan Bera Hindol Mazumdar Tuhinadri Sen

Research Article-Vascular Diseases and Therapeutics (VDT)

April 20, 2017


Troublesome triad: fibrosing mediastinitis, severe pulmonary hypertension, and pulmonary vein stenosis

Gregory W Wigger Jean Elwing

Case Report-Vascular Diseases and Therapeutics (VDT)

May 04, 2017


Influence of endothelial nitric oxide synthase gene SNPs in the delayed cardiopulmonary transition of premature infants

Krishna Yanamandra Sushil K. Jain Arun Pramanik Joseph A. Bocchini Jr Ramasubbareddy Dhanireddy

Research Article-Vascular Diseases and Therapeutics (VDT)

May 25, 2017


Pharmacological management of claudication

Nivas Balasubramaniyam

Commentary Article-Vascular Diseases and Therapeutics (VDT)

June 08, 2017


The effect of a prevention procedure modified by evidence-based nursing on the incidence of lower extremity deep venous thrombosis after stroke

Yanxia Huang Huiping Peng Qiaogen Chen Xin Zhang Xiujun Fan Lilan Xiao Hongmei Tao Lei Zhang

Research Article-Vascular Diseases and Therapeutics (VDT)

June 10, 2017


Hemorrhagic transformation of ischemic stroke

János Marcell László Tibor Hortobágyi

Review Article-Vascular Diseases and Therapeutics (VDT)

June 16, 2017


Endovascular recanalization of superficial femoral artery chronic total occlusions: A multi-disciplinary, single center experience

Aparna Swaminathan Yuliya Lokhnygina David Kopin Michael J. Miller Mitchell W. Cox James S. Mills Lawrence Crawford Manesh R. Patel W. Schuyler Jones

Research Article-Vascular Diseases and Therapeutics (VDT)

April 06, 2017


Rapid reversal of cognitive deficits with high-flow extracranial – Intracranial bypass in cerebral misery perfusion syndrome

Sunil K Munshi Catherine Gaynor David Porter Mohana Maddula Dorothee P. Auer

Case Report-Vascular Diseases and Therapeutics (VDT)

April 07, 2017


Type 1 peritoneal membrane failure in a paediatric patient, successfully treated with icodextrin

Mohammed Azar Malek Oeid Otaibi Flor Khalid Alfakeeh

Case Report-Vascular Diseases and Therapeutics (VDT)

April 10, 2017


Why cholesterol ester transfer protein (CETP) inhibitors have and will likely continue to fail in trials undertaken to increase blood concentrations of HDL-cholesterol and reduce cardiovascular events

Sander J. Robins

Opinion-Vascular Diseases and Therapeutics (VDT)

April 10, 2017


Value of accelerated peritoneal examination time in pediatric nocturnal intermittent peritoneal dialysis

Mohammed Azar Wee-Song Yeo Aamir Omair Khalid Alfakeeh

Research Article-Vascular Diseases and Therapeutics (VDT)

April 13, 2017


Lymphedema: a mini-review on the pathophysiology, diagnosis and treatment

Haitham Shoman Samer Ellahham

Mini-Review-Vascular Diseases and Therapeutics (VDT)

April 15, 2017


Delayed complication of a retrievable inferior vena cava filter

Kruti R Patel Matthew Tong Amit Nautiyal Gary Ansel Jayanta T Mukherjee

Case Report-Vascular Diseases and Therapeutics (VDT)

February 09, 2017


Retrospective analysis of primary and sequential care of type 2 diabetes patients in Taiwan

Ching-Hu Chung

Research Article-Vascular Diseases and Therapeutics (VDT)

February 21, 2017


Non-pharmacological management of claudication - A brief communication to the editor

Nivas Balasubramaniyam

commentary-Vascular Diseases and Therapeutics (VDT)

March 24, 2017


Diabetic neuropathy: Summary of treatment options

Haiju H. Chirayath

commentary-Vascular Diseases and Therapeutics (VDT)

March 27, 2017


Success rate of first haemodialysis post tunnelled dialysis catheter insertion

Dahwa R Martinez-Garcia J Lee C Ratanjee SK

Research Article-Vascular Diseases and Therapeutics (VDT)

March 27, 2017


A rare complication of mediastinal mass biopsy

Kruti Patel Ankur Shah Ryan Kahl Asim Ahmed Sarah Keller Robert Palma Lucia Chowdhury

Short Communication-Vascular Diseases and Therapeutics (VDT)

March 27, 2017


Serum aldosterone and coronary artery disease

Vida Nesarhoseini Mehdi Rasooli Mehrdad Taghipour

Research Article-Vascular Diseases and Therapeutics (VDT)

December 22, 2016


Identification of two novel mutations associated with combined protein C and protein S deficiency

Tyler W Smith Isis SR Carter Valerie C Smith Cedric J Carter Ross TA MacGillivray

Research Article-Vascular Diseases and Therapeutics (VDT)

January 05, 2017


A 36-year-old man with concomitant left ventricular apical thrombus and bilateral acute lower limb ischaemia: Is it only the heart to blame?

Joselyn Rwebembera William Manyilirah James Kayima Emmy Okello Tom Mwambu Michael Oketcho Isaac Ssinabulya Peter Lwabi

Case Series-Vascular Diseases and Therapeutics (VDT)

January 05, 2017


The value of portable renal hilar Doppler ultrasound screening (RHDUS) for renal artery stenosis in critically-ill patients

Jacob Hayes Mohammad Amarneh Janet Pollard Steve Morales Monzer Abu-Yousef

Research Article-Vascular Diseases and Therapeutics (VDT)

January 09, 2017


Antiplatelet therapy in peripheral artery disease - A brief overview

Nivas Balasubramaniyam

Letter to the Editor-Vascular Diseases and Therapeutics (VDT)

January 16, 2017


Resveratrol in vascular diseases and therapeutics

Andrea BALLINI Massimiliano Bruno CINQUE Vittorio DIBELLO Stefania CANTORE

Letter to the Editor-Vascular Diseases and Therapeutics (VDT)

January 20, 2017


Volume 1

Exercise rehabilitation for the treatment of intermittent claudication due to peripheral arterial disease of the lower extremities

Wilbert S. Aronow, MD, FACC, FAHA

Editorial Article-Vascular Diseases and Therapeutics (VDT)

November 4, 2016


Outcomes in culprit only versus multivessel percutaneous coronary intervention in ST elevation myocardial infarction during index procedure

David Wong Waqas Ahmad Waleed Kayani Ameera Ahmed Ihab Hamzeh Salim S. Virani Hani Jneid Nasser Lakkis Mahboob Alam

Research Article-Vascular Diseases and Therapeutics (VDT)

November 10, 2016


Dabigatran for intra-cardiac thrombus; Yet another promising role for novel oral anti-coagulants: A case report

Suresh Krishnamoorthy Tahir Ahmad Mahdi Halim Asok Venkataraman

Case Report-Vascular Diseases and Therapeutics (VDT)

November 21, 2016


An overview of endothelial dysfunction in diabetes

Haiju H Chirayath

Brief commentary-Vascular Diseases and Therapeutics (VDT)

November 24, 2016


Assessment of hemodialysis effect on left ventricular mechanical dyssynchrony by tissue synchronization imaging

Waleed Abdou Ibrahim Hamed Mahmoud Kamel Rehab Yaseen

Research-Vascular Diseases and Therapeutics (VDT)

November 29, 2016


A review of the efficacy and safety of several antihyperglycemic medications in the management of cardiovascular disease in diabetes

Mustafa Kinaan Erin Epstein Suzanne Quinn Martinez

Review-Vascular Diseases and Therapeutics (VDT)

November 30, 2016


Submit Manuscript


VDT welcomes direct submissions from authors: Attach your word file with e-mail and send it to: submissions@oatext.com alternatively to: editor.vdt@oatext.com

Publication Charges


Vascular Diseases and Therapeutics is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Vascular Diseases and Therapeutics are USD 1190 / GBP 960.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

What type of articles are published for free?

Editorials, letters, comments, retractions, etc. will be published for free of charge. APC is applicable for the article types like Research, Review, Mini review, Case Reports, opinions etc.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.